Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of RSS0343 tablets in non-cystic fibrosis bronchiectasis
CTR20250101Phase 2Active
- Sponsor
- Reistone Biopharma
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of RSS0343 in bronchiectasis, sponsored by Reistone Biopharma. Started Feb 2025; status: active.
02
Drugs
RSS0343
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on CTR20250101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250101.